Atlas Trials

Prevention of Autoimmune Destruction and Rejection of Human Pancreatic Islets Following Transplantation for Insulin Dependent Diabetes Mellitus

Clinical trial NCT00501709 · COMPLETED

Trial details

NCT number
NCT00501709
Sponsor
University of California, San Francisco
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Type 1 Diabetes
Start date
2007-02-01
Primary completion
2016-12-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.